Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NHS Genomic Strategy for 2023-2028 released in England

On March 16, 2022, NHS England launched a strategy for embedding genomics in the NHS over the next five years. The document explains what genomics is and why the development of the genomics service is pivotal in England. It sets out priorities for delivering on the NHS vision and ambition over the next five years and how the system will need to work together to improve outcomes for patients and support the continuing scientific and technological advances and discoveries in genomics.

The focus will be on four priority areas:

  • Embedding genomics in the NHS through a world-leading, innovative service model;
  • Delivering equitable genomic testing for improved prediction, prevention, diagnosis, and precision medicine;
  • Enabling genomics to be at the forefront of the data and digital revolution;
  • Evolving the service through cutting-edge science, research, and innovation.

Delivering these actions will require a collaborative and coordinated approach with a range of partners and action from people, teams, and organizations across the NHS. For example, academia, industry, and charities should:

  • Work with the NHS GMS Networks of excellence when established to generate evidence from research for further adoption and spread across the NHS;
  • Work with the NHS to support research in areas identified as priorities through horizon scanning and demand signaling;
  • Engage with the NHS GMS Research Collaborative to utilize the NHS infrastructure for research and innovation projects and initiatives;
  • Work with the national genomic research library to continue to inform diagnostic discovery and to provide insights to evolve healthcare.

See more information here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).